Clinical trial
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
NCT04929028
Study timeline
Study start (actual)2022-08-09Date precision: day
Registry last updated2026-10-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
AIDS-Related Anal Carcinomaunresolved
Anal Margin Squamous Cell Carcinomaunresolved
Anal Squamous Cell Carcinomaunresolved
HIV Infectionunresolved
Rectal Squamous Cell Carcinomaunresolved
Stage II Rectal Cancer AJCC v8unresolved
Stage IIB Anal Cancer AJCC v8unresolved
Stage III Anal Cancer AJCC v8unresolved
Stage III Rectal Cancer AJCC v8unresolved
Interventions
AnoscopyPROCEDURE
Biospecimen CollectionPROCEDURE
CapecitabineDRUG · verified · RxNorm: capecitabine
ColonoscopyPROCEDURE
Computed TomographyPROCEDURE
Digital Rectal ExaminationPROCEDURE
Echocardiography TestPROCEDURE
Fludeoxyglucose F-18OTHER
FluorouracilDRUG · verified · RxNorm: fluorouracil
Lymph Node BiopsyPROCEDURE
Magnetic Resonance ImagingPROCEDURE
MitomycinDRUG · verified · RxNorm: mitomycin
NivolumabBIOLOGICAL
Positron Emission TomographyPROCEDURE
ProctoscopyPROCEDURE
SigmoidoscopyPROCEDURE
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
New YorkNew York, United States3HoustonTexas, United States2The BronxNew York, United States2ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1St LouisMissouri, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04929028 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.